• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
  • For Subscribers
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 20 of 20
Catalent delivers with $871 million biotech IPO
Finance
Catalent delivers with $871 million biotech IPO
By Laura LorenzettiJuly 31, 2014
Wall Street’s next bet: Cures for rare diseases
Features
Wall Street’s next bet: Cures for rare diseases
By Andrew W. LoJanuary 21, 2014
The big bull backup
Features
The big bull backup
By Anne VanderMeySeptember 19, 2013
Lessons from the frontlines of early-stage biotech investing
Finance
Lessons from the frontlines of early-stage biotech investing
By Fortune EditorsFebruary 12, 2013
Stem cell dollars: California leads the way
Tech
Stem cell dollars: California leads the way
By Fortune Editors, Brett Krasnove and Brett KrasnoveSeptember 28, 2012
Advanced prosthetics are about to transform sport
Tech
Advanced prosthetics are about to transform sport
By Rachel TipladyAugust 29, 2012
‘Premature scaling’ in biotech
Finance
‘Premature scaling’ in biotech
By Fortune EditorsSeptember 6, 2011
China: The next biotech superpower?
Tech
China: The next biotech superpower?
By Fortune EditorsAugust 15, 2011
John Martin, Gilead Science CEO
Health
John Martin: Gilead’s disease hunter
By Geoff ColvinMay 23, 2011
1...
  • 16
  • 17
  • 18
  • 19
  • 20
20
Most Popular
AI
The Trump White House is starting to admit that your bank account and airline tickets are under attack from rogue AIplaceholder alt text
By Nick LichtenbergNovember 17, 2026
Commentary
If it looks like a DDoS attackplaceholder alt text
By Matthew AndrianiNovember 17, 2026
Health
The man who sold Aetna to CVS for almost $70 billion says the deal was cover for problems ‘they never really fixed’—just as CVS breaks itself in twoplaceholder alt text
By Nick LichtenbergNovember 17, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.